Boston’s own Brigham and Women’s Hospital will serve as the clinical research site for a Phase 3 trial of Moderna’s highly-anticipated coronavirus vaccine, which has already elicited positive immune responses in volunteers of previous trials.
Boston’s own Brigham and Women’s Hospital will serve as the clinical research site for a Phase 3 trial of Moderna’s highly-anticipated coronavirus vaccine, which has already elicited positive immune responses in volunteers of previous trials.
The Phase 3 trial of the coronavirus vaccine, the world’s biggest COVID-19 vaccine study with 30,000 planned volunteers, got underway on Monday.
The study will enroll participants at a number of locations throughout the United States, with BWH serving as a clinical research site as part of the COVID-19 Prevention Network, a group funded by the National Institutes of Health.
“This is the first phase 3 trial that will test the effectiveness of a vaccine against COVID-19, and we’ve been working diligently across industry, academia and government to pave a path for launching this trial rapidly and safely,” said Dr.
